Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs
about
Safety of Seasonal Malaria Chemoprevention (SMC) with Sulfadoxine-Pyrimethamine plus Amodiaquine when Delivered to Children under 10 Years of Age by District Health Services in Senegal: Results from a Stepped-Wedge Cluster Randomized TrialIn vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa).Extracts from "Clinical Evidence". Malaria: prevention in travellers.Adverse reactions to sulfa drugs: implications for malaria chemotherapy.Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural TanzThe efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparumAmodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes.Evaluation of Two Strategies for Community-Based Safety Monitoring during Seasonal Malaria Chemoprevention Campaigns in Senegal, Compared with the National Spontaneous Reporting System.
P2860
Q28552803-6F8F0FE5-B835-47B7-AB93-7D7FEE0FCB81Q33395221-C4A6B650-3CF8-4363-9114-688FCA02799AQ33720539-FEE5CE3B-405E-4C2C-9C66-CBEEFD9DA91FQ33801237-6BF9F95C-ABC8-4EFA-9D3E-14BF3E3332EEQ34860367-74EA4151-3559-417B-B1A7-EE581E020D75Q37009500-74EA57EA-82DE-4C30-844F-55BC51327549Q37144195-A86AC5AC-3423-462A-872B-6B5CBE7DD22FQ37423034-3EC9114B-09F6-4C97-B431-DC47F690AFCAQ55410478-1BF5E40F-B365-40AC-9D56-788E8E58D2A4
P2860
Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Ascertainment of risk of serio ...... rophylactic antimalarial drugs
@ast
Ascertainment of risk of serio ...... rophylactic antimalarial drugs
@en
type
label
Ascertainment of risk of serio ...... rophylactic antimalarial drugs
@ast
Ascertainment of risk of serio ...... rophylactic antimalarial drugs
@en
prefLabel
Ascertainment of risk of serio ...... rophylactic antimalarial drugs
@ast
Ascertainment of risk of serio ...... rophylactic antimalarial drugs
@en
P2860
P1476
Ascertainment of risk of serio ...... rophylactic antimalarial drugs
@en
P2093
Bjorkman AB
Phillips-Howard PA
P2860
P304
P407
P577
1990-01-01T00:00:00Z